1887

Chapter 56 : Rubella Virus

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Ebook: Choose a downloadable PDF or ePub file. Chapter is a downloadable PDF file. File must be downloaded within 48 hours of purchase

Buy this Chapter
Digital (?) $30.00

Preview this chapter:
Zoom in
Zoomout

Rubella Virus, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555819439/9781555819422.ch56-1.gif /docserver/preview/fulltext/10.1128/9781555819439/9781555819422.ch56-2.gif

Abstract:

Rubella is a benign disease when acquired by a child or adult, but causes significant sequelae to a developing fetus when intrauterine transmission occurs. Following the devastating worldwide pandemic in 1962–1965, a safe and effective rubella vaccine was developed and widely utilized. As a consequence, the occurrence of congenital rubella syndrome has decreased dramatically in those regions of the world with rubella vaccination programs. In 2015 the Americas region became the first World Health Organization (WHO) region in the world to be declared free of endemic transmission of rubella. Despite this, rubella continues to circulate in other parts of the world, including a large outbreak in Japan occurring since 2012, and approximately 100,000 cases of congenital rubella syndrome still occur worldwide. Given the ease and frequency of global travel, however, clinicians need to remain aware of rubella even in the United States, so that imported cases can be identified and managed accordingly. This chapter reviews the current knowledge of the natural history, pathogenesis, diagnosis, treatment, and prevention of rubella.

Citation: Kimberlin D. 2017. Rubella Virus, p 1381-1393. In Richman D, Whitley R, Hayden F (ed), Clinical Virology, Fourth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555819439.ch56
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

Figures

Image of FIGURE 1
FIGURE 1

Number of rubella and congenital rubella syndrome (CRS) cases—United States, 1966–2011. Source: Rubella and CRS data provided were reported voluntarily to CDC from state health departments. * By year of birth. (Reprinted from reference with permission.)

Citation: Kimberlin D. 2017. Rubella Virus, p 1381-1393. In Richman D, Whitley R, Hayden F (ed), Clinical Virology, Fourth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555819439.ch56
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 2
FIGURE 2

Likelihood and outcome of congenital rubella syndrome as a function of time of acquisition of maternal rubella virus infection. Hatched bars, rate of fetal infection; striped bars, rate of defects in infected persons; diamonds, overall risk of defects after maternal infection. (Adapted from reference with permission.)

Citation: Kimberlin D. 2017. Rubella Virus, p 1381-1393. In Richman D, Whitley R, Hayden F (ed), Clinical Virology, Fourth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555819439.ch56
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 3
FIGURE 3

Schematic of the immune response in acute rubella virus infection. Values on the axis indicate number of days. RIA, radioimmunoassay; EIA, enzyme immunoassay; HI, hemagglutination inhibition; LA, latex agglutination; FIA/FIAX and IFA, immunofluorescence; Nt, neutralization; PHA, passive agglutination. (Reprinted from reference with permission.)

Citation: Kimberlin D. 2017. Rubella Virus, p 1381-1393. In Richman D, Whitley R, Hayden F (ed), Clinical Virology, Fourth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555819439.ch56
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 4
FIGURE 4

Schematic of the immune response in the mother, fetus, and infant after maternal and fetal rubella virus infections in the first trimester of pregnancy. (Reprinted from reference with permission.)

Citation: Kimberlin D. 2017. Rubella Virus, p 1381-1393. In Richman D, Whitley R, Hayden F (ed), Clinical Virology, Fourth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555819439.ch56
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 5
FIGURE 5

(Left) Provisional zones of calcification are poorly defined and irregular. Radiolucent defects are present in metaphyses of femora and tibiae and the parallel long axis of the bone. (Right) Lower extremities 2 months later show nearly complete disappearance of osseous abnormalities. (Reprinted from reference with permission.)

Citation: Kimberlin D. 2017. Rubella Virus, p 1381-1393. In Richman D, Whitley R, Hayden F (ed), Clinical Virology, Fourth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555819439.ch56
Permissions and Reprints Request Permissions
Download as Powerpoint

References

/content/book/10.1128/9781555819439.ch56
1. Cherry JD,. 1992. Rubella, p 17921817. In Feigin RD, Cherry JD (ed), Textbook of Pediatric Infectious Diseases, 3rd ed. W.B. Saunders Company, Philadelphia.
2. Emminghaus H. 1870. Uber rubeolen. Jahrb Kinder 4:4759.
3. Wesselhoeft C. 1947. Rubella (German measles). N Engl J Med 236:943950, passim.[PubMed]
4. Willan (cited by G. Gregory). 1843. Lectures on the eruptive fevers, p. 102, Lectures on the Eruptive Fevers. Henry Renshaw, London, United Kingdom.
5. Maton WG. 1815. Some account of rash, liable to be mistaken for scarlatina. Med Trans R Coll Physicians 5:149165.
6. Homans J. 1848. Roetheln. Boston Society for Medical Improvement, Records of Meetings, Boston Medical Library 5:370.
7. Veale H. 1866. History of epidemic of Rotheln, with observations on its pathology. Edinburgh Med J 12:404414.
8. Forbes JA. 1969. Rubella: historical aspects. Am J Dis Child 118:511.[PubMed]
9. Transactions of the International Congress of Medicine. 1881. Trans Intl Congr Med 4:1434.
10. Shapiro L. 1965. The numbered diseases: first through sixth. JAMA 194:680.[PubMed]
11. Gregg NM. 1941. Congenital cataract following German measles in the mother. Trans Ophthalmol Soc Aust 3:3546.
12. Forrest JM, Turnbull FM, Sholler GF, Hawker RE, Martin FJ, Doran TT, Burgess MA. 2002. Gregg's congenital rubella patients 60 years later. Med J Aust 177:664667.[PubMed]
13. Swan C, Tostevin AL, Moore B, Mayo H,, and Black GHB. 1943. Congenital defects in infants following infectious diseases during pregnancy. With special reference to the relationship between German measles and cataract, deaf-mutism, heart disease and microcephaly, and to the period of pregnancy in which the occurence of rubella is followed by congenital abnormalities. Med J Aust 2:201210.
14. Swan C, Tostevin AL, Moore B, Mayo H,, and Black GHB. 1944. Further observations on congenital defects in infants following infectious diseases during pregnancy, with special reference to rubella. Med J Aust 1:409413.
15. Evans MW. 1944. Congenital dental defects in infants subsequent to maternal rubella during pregnancy. Med J Aust 2:225228.
16. Erickson CA. 1944. Rubella early in pregnancy causing congenital malformations of eyes and heart. J Pediatr 25:281283.
17. Martin SM. 1945. Congenital defects and rubella. BMJ 1:855.[PubMed]
18. Wesselhoeft C. 1947. Rubella (German measles). N Engl J Med 236:978988.[PubMed]
19. Hiro Y, Tasaka S. 1938. Die roteln sind eine viruskrankheit. Monatschr Kinderh 76:328332.
20. Habel K. 1942. Transmission of rubella to Macacus mulatta monkeys. Public Health Rep 57:11261139.
21. Weller TH, Neva FA. 1962. Propagation in tissue culture of cytopathic agents from patients with rubella-like illness. Proc Soc Exp Biol Med 111:215225.
22. Parkman PD, Buescher EL, Artenstein MS. 1962. Recovery of rubella virus from army recruits. Proc Soc Exp Biol Med 111:225230.[PubMed]
23. Meyer HM Jr, Parkman PD, Hobbins TE, Larson HE, Davis WJ, Simsarian JP, Hopps HE. 1969. Attenuated rubella viruses. Laboratory and clinical characteristics. Am J Dis Child 118:155165.[PubMed]
24. Prinzie A, Huygelen C, Gold J, Farquhar J, McKee J. 1969. Experimental live attenuated rubella virus vaccine. Clinical evaluation of Cendehill strain. Am J Dis Child 118:172177.[PubMed]
25. Plotkin SA, Farquhar JD, Katz M, Buser F. 1969. Attenuation of RA 27-3 rubella virus in WI-38 human diploid cells. Am J Dis Child 118:178185.[PubMed]
26. Krugman SE. 1969. International Conference on Rubella Immunization. Am J Dis Child 118:5410.
27. Meyer HM Jr, Hopps HE, Parkman PD, Ennis FA. 1978. Control of measles and rubella through use of attenuated vaccines. Am J Clin Pathol 70(Suppl):128135.[PubMed]
28. Meyer HM Jr, Parkman PD, Panos TC. 1966. Attenuated rubella virus. II. Production of an experimental live-virus vaccine and clinical trial. N Engl J Med 275:575580.[PubMed]
29. Perkins FT. 1985. Licensed vaccines. Rev Infect Dis 7(Suppl 1):S73S76.[PubMed]
30. Plotkin SA,. 1988. Rubella vaccine, p 235262. In Plotkin EAJMSA (ed), Vaccines. WB Saunders, Philadelphia.
31. Centers for Disease Control and Prevention (CDC). 2005. Elimination of rubella and congenital rubella syndrome—United States, 1969–2004. MMWR Morb Mortal Wkly Rep 54:279282.[PubMed]
32. McCarthy M. 2015. Endemic rubella is eliminated from Americas, PAHO announces. BMJ 350:h2348.[PubMed]
33. Zheng DP, Frey TK, Icenogle J, Katow S, Abernathy ES, Song KJ, Xu WB, Yarulin V, Desjatskova RG, Aboudy Y, Enders G, Croxson M. 2003. Global distribution of rubella virus genotypes. Emerg Infect Dis 9:15231530.[PubMed]
34. Chantler JK. 1979. Rubella virus: intracellular polypeptide synthesis. Virology 98:275278.[PubMed]
35. Best JM, Banatvala JE. 1970. Studies on rubella virus strain variation by kinetic haemagglutination-inhibition tests. J Gen Virol 9:215223.[PubMed]
36. Alain R, Nadon F, Séguin C, Payment P, Trudel M. 1987. Rapid virus subunit visualization by direct sedimentation of samples on electron microscope grids. J Virol Methods 16:209216.[PubMed]
37. Bardeletti G, Kessler N, Aymard-Henry M. 1975. Morphology, biochemical analysis and neuraminidase activity of rubella virus. Arch Virol 49:175186.[PubMed]
38. Holmes IH, Wark MC, Warburton MF. 1969. Is rubella an arbovirus? II. Ultrastructural morphology and development. Virology 37:1525.[PubMed]
39. Pettersson RF, Oker-Blom C, Kalkkinen N, Kallio A, Ulmanen I, Kääriäinen L, Partanen P, Vaheri A. 1985. Molecular and antigenic characteristics and synthesis of rubella virus structural proteins. Rev Infect Dis 7(Suppl 1):S140S149.[PubMed]
40. Sedwick WD, Sokol F. 1970. Nucleic acid of rubella virus and its replication in hamster kidney cells. J Virol 5:478489.[PubMed]
41. Wolinsky JS,. 1990. Rubella, p 815838. In Fields BN, Knipe DM, Chanock RM, Hirsch MS, Melnick JL, Monath TP, Roizman B (ed), Virology, 2nd ed. Raven Press, New York.
42. Hemphill ML, Forng RY, Abernathy ES, Frey TK. 1988. Time course of virus-specific macromolecular synthesis during rubella virus infection in Vero cells. Virology 162:6575.[PubMed]
43. Parkman PD, Phillips PE, Kirschstein RL, Meyer HM Jr. 1965. Experimental rubella virus infection in the rhesus monkey. J Immunol 95:743752.[PubMed]
44. Horstmann DM. 1969. Discussion paper: the use of primates in experimental viral infections—rubella and the rubella syndrome. Ann N Y Acad Sci 162:594597.[PubMed]
45. Parkman PD, Phillips PE, Meyer HM Jr. 1965. Experimental rubella virus infection in pregnant monkeys. Am J Dis Child 110:390394.[PubMed]
46. Sever JL, Meier GW, Windle WF, Schiff GM, Monif GR, Fabiyi A. 1966. Experimental rubella in pregnant rhesus monkeys. J Infect Dis 116:2126.[PubMed]
47. Cooper LZ, Preblud SR, Alford CA Jr,. 1995. Rubella, p 268311. In Remington JS, Klein JO (ed), Infectious Diseases of the Fetus and Newborn Infant, 4th ed. WB Saunders Company, Philadelphia.
48. Parkman PD, Buescher EL, Artenstein MS, McCown JM, Mundon FK, Druzd AD. 1964. Studies of Rubella. I. Properties of the Virus. J Immunol 93:595607.[PubMed]
49. Wallis C, Melnick JL, Rapp F. 1965. Different effects of MgC1-2 and MgSO-4 on the thermostability of viruses. Virology 26:694699.[PubMed]
50. Chagnon A, Laflamme P. 1964. Effect of acidity on rubella virus. Can J Microbiol 10:501502.[PubMed]
51. Plotkin SA,. 1969. Rubella virus, p 364. In Lennette NJSEH (ed), Diagnostic Procedures for Viral and Rickettsial Infections. American Public Health Association, New York.
52. Clarke M, Schild GC, Boustred J, McGregor IA, Williams K. 1980. Epidemiological studies of rubella virus in a tropical African community. Bull World Health Organ 58:931935.[PubMed]
53. Hillenbrand FK. 1956. Rubella in a remote community. Lancet 271:6466.[PubMed]
54. Gale JL, Detels R, Kim KS, Beasley RP, Chen KP, Grayston JT. 1972. The epidemiology of rubella on Taiwan. 3. Family studies in cities of high and low attack rates. Int J Epidemiol 1:261265.[PubMed]
55. Grayston JT, Gale JL, Watten RH. 1972. The epidemiology of rubella on Taiwan. I. Introduction and description of the 1957–1958 epidemic. Int J Epidemiol 1:245252.[PubMed]
56. Anonymous, Centers for Disease Control (CDC). 1989. Rubella and congenital rubella syndrome—United States, 1985–1988. MMWR Morb Mortal Wkly Rep 38:173178.[PubMed]
57. Anonymous, Centers for Disease Control and Prevention (CDC). 1994. Rubella and congenital rubella syndrome—United States, January 1, 1991-May 7, 1994. MMWR Morb Mortal Wkly Rep 43(21):391, 397–401.[PubMed]
58. Horstmann DM,. 1990. Rubella, p 617. In Evans AS (ed), Viral Infections of Humans: Epidemiology and Control, 3rd ed. Plenum Medical Book Company, New York.
59. Horstmann DM. 1971. Rubella: the challenge of its control. J Infect Dis 123:640654.[PubMed]
60. Pollard RB, Edwards EA. 1975. Epidemiologic survey of rubella in a military recruit population. Am J Epidemiol 101:431437.[PubMed]
61. Horstmann DM, Riordan JT, Ohtawara M, Niederman JC. 1965. A natural epidemic of rubella in a closed population: virological and epidemiological observations. Arch Gesamte Virusforsch 16:483487.[PubMed]
62. Horstmann DM, Liebhaber H, Le Bouvier GL, Rosenberg DA, Halstead SB. 1970. Rubella: reinfection of vaccinated and naturally immune persons exposed in an epidemic. N Engl J Med 283:771778.[PubMed]
63. Wilkins J, Leedom JM, Salvatore MA, Portnoy B. 1972. Clinical rubella with arthritis resulting from reinfection. Ann Intern Med 77:930932.[PubMed]
64. Davis WJ, Larson HE, Simsarian JP, Parkman PD, Meyer HM Jr. 1971. A study of rubella immunity and resistance to infection. JAMA 215:600608.[PubMed]
65. Wilkins J, Leedom JM, Portnoy B, Salvatore MA. 1969. Reinfection with rubella virus despite live vaccine induced immunity. Trials of HPV-77 and HPV-80 live rubella virus vaccines and subsequent artificial and natural challenge studies. Am J Dis Child 118:275294.[PubMed]
66. Forsgren M, Sörén L. 1985. Subclinical rubella reinfection in vaccinated women with rubella-specific IgM response during pregnancy and transmission of virus to the fetus. Scand J Infect Dis 17:337341.[PubMed]
67. Das BD, Lakhani P, Kurtz JB, Hunter N, Watson BE, Cartwright KA, Caul EO, Roome AP. 1990. Congenital rubella after previous maternal immunity. Arch Dis Child 65:545546.[PubMed]
68. Roush SW, Murphy TV Vaccine-Preventable Disease Table Working Group. 2007. Historical comparisons of morbidity and mortality for vaccine-preventable diseases in the United States. JAMA 298:21552163.[PubMed]
69. Centers for Disease Control and Prevention. 2013. Three cases of congenital rubella syndrome in the postelimination era—Maryland, Alabama, and Illinois, 2012. Pediatr Infect Dis J. 32:889897.
70. Lebo EJ, Kruszon-Moran DM, Marin M, Bellini WJ, Schmid S, Bialek SR, Wallace GS,, and McLean HQ. 2015. Seroprevalence of measles, mumps, rubella and varicella antibodies in the United States population, 2009–2010. Open Forum Infect Dis. 2:ofv006.
71. Fenner F. 1998. Candidate viral diseases for elimination or eradication. Bull World Health Organ 76(Suppl 2):6870.[PubMed]
72. Watson JC, Hadler SC, Dykewicz CA, Reef S, Phillips L. 1998. Measles, mumps, and rubella—vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 47(RR-8):157.[PubMed]
73. Plotkin SA, Katz M, Cordero JF. 1999. The eradication of rubella. JAMA 281:561562.[PubMed]
74. Meissner HC, Reef SE, Cochi S. 2006. Elimination of rubella from the United States: a milestone on the road to global elimination. Pediatrics 117:933935.[PubMed]
75. Plotkin SA. 2006. The history of rubella and rubella vaccination leading to elimination. Clin Infect Dis 43(Suppl 3):S164S168.[PubMed]
76. Sugishita Y,. Shimatani N,. Katow S,. Takahashi T,. and Hori N.. 2015. Epidemiological characteristics of rubella and congenital rubella syndrome in the 2012–2013 epidemics in Tokyo, Japan. Jpn J Infect Dis 68:159165.
77. Lambert N, Strebel P, Orenstein W, Icenogle J, Poland GA. 2015. Rubella. Lancet. 385:22972307.
78. Witte JJ, Karchmer AW, Case G, Herrmann KL, Abrutyn E, Kassanoff I, Neill JS. 1969. Epidemiology of rubella. Am J Dis Child 118:107111.[PubMed]
79. Green RH, Balsamo MR, Giles JP, Krugman S, Mirick GS. 1965. Studies of the natural history and prevention of rubella. Am J Dis Child 110:348365.[PubMed]
80. Heggie AD, Robbins FC. 1969. Natural rubella acquired after birth. Clinical features and complications. Am J Dis Child 118:1217.[PubMed]
81. American Academy of Pediatrics. 2015. Rubella, p 688695. In Kimberlin DW, Brady MT, Jackson MA, Long SS (ed), Red Book: 2015 Report of the Committee on Infectious Diseases, 30th ed. American Academy of Pediatrics, Elk Grove Village, IL.
82. Schiff GM, Dine MS. 1965. Transmission of rubella from newborns. A controlled study among young adult women and report of an unusual case. Am J Dis Child 110:447451.[PubMed]
83. Rawls WE, Phillips A, Melnick JL, Desmond MM. 1967. Persistent virus infection in congenital rubella. Arch Ophthalmol 77:430433.[PubMed]
84. Cooper LZ,. 1968. Rubella: a preventable cause of birth defects, p 23. In Bergman D (ed), Intrauterine Infections. The National Foundation, New York.
85. Greaves WL, Orenstein WA, Stetler HC, Preblud SR, Hinman AR, Bart KJ. 1982. Prevention of rubella transmission in medical facilities. JAMA 248:861864.[PubMed]
86. Hattis RP, Halstead SB, Herrmann KL, Witte JJ. 1973. Rubella in an immunized island population. JAMA 223:10191021.[PubMed]
87. Honeyman MC, Dorman DC, Menser MA, Forrest JM, Guinan JJ, Clark P. 1975. HL-A antigens in congenital rubella and the role of antigens 1 and 8 in the epidemiology of natural rubella. Tissue Antigens 5:1218.[PubMed]
88. Miller E, Cradock-Watson JE, Pollock TM. 1982. Consequences of confirmed maternal rubella at successive stages of pregnancy. Lancet 2:781784.[PubMed]
89. Cradock-Watson JE, Ridehalgh MK, Anderson MJ, Pattison JR, Kangro HO. 1980. Fetal infection resulting from maternal rubella after the first trimester of pregnancy. J Hyg (Lond) 85:381391.[PubMed]
90. Peckham CS. 1972. Clinical and laboratory study of children exposed in utero to maternal rubella. Arch Dis Child 47:571577.[PubMed]
91. Mellinger AK, Cragan JD, Atkinson WL, Williams WW, Kleger B, Kimber RG, Tavris D. 1995. High incidence of congenital rubella syndrome after a rubella outbreak. Pediatr Infect Dis J 14:573578.[PubMed]
92. Anonymous. 1976. Reported morbidity and mortality for the United States, 1975. MMWR Morb Mortal Wkly Rep 24:2.
93. Töndury G, Smith DW. 1966. Fetal rubella pathology. J Pediatr 68:867879.[PubMed]
94. Driscoll SG. 1969. Histopathology of gestational rubella. Am J Dis Child 118:4953.[PubMed]
95. Bowden DS, Pedersen JS, Toh BH, Westaway EG. 1987. Distribution by immunofluorescence of viral products and actin-containing cytoskeletal filaments in rubella virus-infected cells. Arch Virol 92:211219.[PubMed]
96. Naeye RL, Blanc W. 1965. Pathogenesis of congenital rubella. JAMA 194:12771283.[PubMed]
97. Cubie H, Edmond E. 1985. Comparison of five different methods of rubella IgM antibody testing. J Clin Pathol 38:203207.[PubMed]
98. Pattison JR. 1975. Persistence of specific IgM after natural infection with rubella virus. Lancet 1:185187.[PubMed]
99. Böttiger B, Jensen IP. 1997. Maturation of rubella IgG avidity over time after acute rubella infection. Clin Diagn Virol 8:105111.[PubMed]
100. Gutiérrez J, Rodríguez MJ, De Ory F, Piédrola G, Maroto MC. 1999. Reliability of low-avidity IgG and of IgA in the diagnosis of primary infection by rubella virus with adaptation of a commercial test. J Clin Lab Anal 13:14.[PubMed]
101. Enders G, Knotek F. 1989. Rubella IgG total antibody avidity and IgG subclass-specific antibody avidity assay and their role in the differentiation between primary rubella and rubella reinfection. Infection 17:218226.[PubMed]
102. Mori T, Shiozawa K. 1985. Suppression of tuberculin hypersensitivity caused by rubella infection. Am Rev Respir Dis 131:886888.[PubMed]
103. Grangeot-Keros L, Pillot J, Daffos F, Forestier F. 1988. Prenatal and postnatal production of IgM and IgA antibodies to rubella virus studied by antibody capture immunoassay. J Infect Dis 158:138143.[PubMed]
104. Cradock-Watson JE, Ridehalgh MK. 1976. Specific immunoglobulins in infants with the congenital rubella syndrome. J Hyg (Lond) 76:109123.[PubMed]
105. Cooper LZ, Florman AL, Ziring PR, Krugman S. 1971. Loss of rubella hemagglutination inhibition antibody in congenital rubella. Failure of seronegative children with congenital rubella to respond to HPV-77 rubella vaccine. Am J Dis Child 122:397403.[PubMed]
106. Ueda K, Tokugawa K, Fukushige J, Yoshikawa H, Nonaka S. 1987. Hemagglutination inhibition antibodies in congenital rubella syndrome. A 17-year follow-up in the Ryukyu Islands. Am J Dis Child 141:211212.[PubMed]
107. Herne V, Hedman K, Reedik P. 1997. Immunoglobulin G avidity in the serodiagnosis of congenital rubella syndrome. Eur J Clin Microbiol Infect Dis 16:763766.[PubMed]
108. Buimovici-Klein E, Lang PB, Ziring PR, Cooper LZ. 1979. Impaired cell-mediated immune response in patients with congenital rubella: correlation with gestational age at time of infection. Pediatrics 64:620626.[PubMed]
109. Schiff GM, Sever JL, Huebner RJ. 1965. Experimental rubella. Clinical and laboratory findings. Arch Intern Med 116:537543.[PubMed]
110. Forcheimer F. 1898. The enanthem of German measles. Trans Am Pediatr Soc 10:118128.
111. Wesselhoeft C. 1947. Rubella (German measles). N Engl J Med 236:943950, passim.[PubMed]
112. de Groot-Mijnes JD, de Visser L, Rothova A, Schuller M, van Loon AM, Weersink AJ. 2006. Rubella virus is associated with fuchs heterochromic iridocyclitis. Am J Ophthalmol 141:212214.[PubMed]
113. Siemerink MJ, Sijssens KM, de Groot-Mijnes JD, de Boer JH. 2007. Rubella virus-associated uveitis in a nonvaccinated child. Am J Ophthalmol 143:899900.[PubMed]
114. Tingle AJ, Allen M, Petty RE, Kettyls GD, Chantler JK. 1986. Rubella-associated arthritis. I. Comparative study of joint manifestations associated with natural rubella infection and RA 27/3 rubella immunisation. Ann Rheum Dis 45:110114.[PubMed]
115. Vergani D, Morgan-Capner P, Davies ET, Anderson AW, Tee DE, Pattison JR. 1980. Joint symptoms, immune complexes, and rubella. Lancet 2:321322.[PubMed]
116. Singh VK, Tingle AJ, Schulzer M. 1986. Rubella-associated arthritis. II. Relationship between circulating immune complex levels and joint manifestations. Ann Rheum Dis 45:115119.[PubMed]
117. Chantler JK, Tingle AJ, Petty RE. 1985. Persistent rubella virus infection associated with chronic arthritis in children. N Engl J Med 313:11171123.[PubMed]
118. Chantler JK, da Roza DM, Bonnie ME, Reid GD, Ford DK. 1985. Sequential studies on synovial lymphocyte stimulation by rubella antigen, and rubella virus isolation in an adult with persistent arthritis. Ann Rheum Dis 44:564568.[PubMed]
119. Ford DK, Reid GD, Tingle AJ, Mitchell LA, Schulzer M. 1992. Sequential follow up observations of a patient with rubella associated persistent arthritis. Ann Rheum Dis 51:407410.[PubMed]
120. Cunningham AL, Fraser JR. 1985. Persistent rubella virus infection of human synovial cells cultured in vitro. J Infect Dis 151:638645.[PubMed]
121. Miki NP, Chantler JK. 1992. Differential ability of wild-type and vaccine strains of rubella virus to replicate and persist in human joint tissue. Clin Exp Rheumatol 10:312.[PubMed]
122. Ueda K, Sasaki F, Tokugawa K, Segawa K, Fujii H. 1984. The 1976–1977 rubella epidemic in Fukuoka city in southern Japan: epidemiology and incidences of complications among 80,000 persons who were school children at 28 primary schools and their family members. Biken J 27:161168.[PubMed]
123. Margolis FJ, Wilson JL, Top FH. 1943. Postrubella encephalomyelitis. Report of cases in Detroit and review of the literature. J Pediatr 23:158165.
124. Gershon AA,. 1995. Rubella virus (German measles), p 14591465. In Mandel JEBGL, Dolin R (ed), Principles and Practice of Infectious Diseases, 4th ed. Churchill Livingstone, New York.
125. Townsend JJ, Baringer JR, Wolinsky JS, Malamud N, Mednick JP, Panitch HS, Scott RA, Oshiro L, Cremer NE. 1975. Progressive rubella panencephalitis. Late onset after congenital rubella. N Engl J Med 292:990993.[PubMed]
126. Sever JL, South MA, Shaver KA. 1985. Delayed manifestations of congenital rubella. Rev Infect Dis 7(Suppl 1):S164S169.[PubMed]
127. Clarke WL, Shaver KA, Bright GM, Rogol AD, Nance WE. 1984. Autoimmunity in congenital rubella syndrome. J Pediatr 104:370373.[PubMed]
128. Terry GM, Ho-Terry L, Warren RC, Rodeck CH, Cohen A, Rees KR. 1986. First trimester prenatal diagnosis of congenital rubella: a laboratory investigation. Br Med J (Clin Res Ed) 292:930933.[PubMed]
129. Ho-Terry L, Terry GM, Londesborough P, Rees KR, Wielaard F, Denissen A. 1988. Diagnosis of fetal rubella infection by nucleic acid hybridization. J Med Virol 24:175182.[PubMed]
130. Zhao LH, Ma YY, Wang H, Zhao SP, Zhao WM, Li H, Wang LY. 2006. Establishment and application of a TaqMan real-time quantitative reverse transcription-polymerase chain reaction assay for rubella virus RNA. Acta Biochim Biophys Sin (Shanghai) 38:731736.[PubMed]
131. Mubareka S, Richards H, Gray M, Tipples GA. 2007. Evaluation of commercial rubella immunoglobulin G avidity assays. J Clin Microbiol 45:231233.[PubMed]
132. Sever JL, Huebner RJ, Castellano GA, Sarma PS, Fabiyi A, Schiff GM, Cusumano CL. 1965. Rubella Complement Fixation Test. Science 148:385387.[PubMed]
133. Stewart GL, Parkman PD, Hopps HE, Douglas RD, Hamilton JP, Meyer HM Jr. 1967. Rubella-virus hemagglutination-inhibition test. N Engl J Med 276:554557.[PubMed]
134. Schmidt NJ, Styk B. 1968. Immunodiffusion reactions with rubella antigens. J Immunol 101:210216.[PubMed]
135. Vaheri A, Vesikari T. 1971. Small size rubella virus antigens and soluble immune complexes: analysis by the platelet aggregation technique. Arch Gesamte Virusforsch 35:1024.[PubMed]
136. Brown GC, Maassab HF, Veronelli JA, Francis TJ Jr. 1964. Rubella antibodies in human serum: detection by the indirect fluorescent antibody technic. Science 145:943945.[PubMed]
137. Vejtorp M. 1978. Enzyme-linked immunosorbent assay for determination of rubella IgG antibodies. Acta Pathol Microbiol Scand [B] 86B:387392.[PubMed]
138. Kimberlin DW. 1997. Rubella immunization. Pediatr Ann 26:366370.[PubMed]
139. Martin du Pan R, Koechli B, Douath A. 1972. Protection of nonimmune volunteers against rubella by intravenous administration of normal human gamma globulin. J Infect Dis 126:341344.[PubMed]
140. Doege TC, Kim KS. 1967. Studies of rubella and its prevention with immune globulin. JAMA 200:584590.[PubMed]
141. Public Health Laboratory Service Working Party on Rubella. 1970. Studies of the effect of immunoglobulin on rubella in pregnancy. Report of the Public Health Laboratory Service Working Party on rubella. BMJ 2:497500.[PubMed]
142. Ovsyannikova IG, Jacobson RM, Ryan JE, Dhiman N, Vierkant RA, Poland GA. 2007. Relationship between HLA polymorphisms and gamma interferon and interleukin-10 cytokine production in healthy individuals after rubella vaccination. Clin Vaccine Immunol 14:115122.[PubMed]
143. Ovsyannikova IG, Jacobson RM, Vierkant RA, Pankratz VS, Poland GA. 2007. HLA supertypes and immune responses to measles-mumps-rubella viral vaccine: findings and implications for vaccine design. Vaccine 25:30903100.[PubMed]
144. D'Angio CT, Boohene PA, Mowrer A, Audet S, Menegus MA, Schmid DS, Beeler JA. 2007. Measles-mumps-rubella and varicella vaccine responses in extremely preterm infants. Pediatrics 119:e574e579.[PubMed]
145. Miller E, Waight P, Farrington CP, Andrews N, Stowe J, Taylor B. 2001. Idiopathic thrombocytopenic purpura and MMR vaccine. Arch Dis Child 84:227229.[PubMed]
146. Howe CJ, Howson CP,. 1991. Adverse effects of pertussis and rubella vaccines. In Howe CJ, Howson CP, Fineberg HV (ed), Adverse Effects of Pertussis and Rubella Vaccines. National Academy Press, Washington, D.C.
147. Howson CP, Katz M, Johnston RB Jr, Fineberg HV. 1992. Chronic arthritis after rubella vaccination. Clin Infect Dis 15:307312.[PubMed]
148. Ray P, Black S, Shinefield H, Dillon A, Schwalbe J, Holmes S, Hadler S, Chen R, Cochi S, Wassilak S Vaccine Safety Datalink Team. 1997. Risk of chronic arthropathy among women after rubella vaccination. JAMA 278:551556.[PubMed]
149. Tingle AJ, Mitchell LA, Grace M, Middleton P, Mathias R, MacWilliam L, Chalmers A. 1997. Randomised double-blind placebo-controlled study on adverse effects of rubella immunisation in seronegative women. Lancet 349:12771281.[PubMed]
150. Bosma TJ, Etherington J, O'Shea S, Corbett K, Cottam F, Holt L, Banatvala JE, Best JM. 1998. Rubella virus and chronic joint disease: is there an association? J Clin Microbiol 36:35243526.[PubMed]
151. Wakefield AJ, Murch SH, Anthony A, Linnell J, Casson DM, Malik M, Berelowitz M, Dhillon AP, Thomson MA, Harvey P, Valentine A, Davies SE, Walker-Smith JA. 1998. Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet 351:637641.[PubMed]
152. Murch SH, Anthony A, Casson DH, Malik M, Berelowitz M, Dhillon AP, Thomson MA, Valentine A, Davies SE, Walker-Smith JA. 2004. Retraction of an interpretation. Lancet 363:750.[PubMed]
153. Horton R. 2004. A statement by the editors of The Lancet. Lancet 363:820821.[PubMed]
154. Immunization Safety Review Committee. 2004. Immunization Safety Review. In Institute of Medicine (ed.), Vaccines and Autism Board of Health Promotion and Disease Prevention. National Academy Press, Washington, D.C.
155. DeStefano F. 2007. Vaccines and autism: evidence does not support a causal association. Clin Pharmacol Ther 82:756759.[PubMed]
156. Sukumaran L, McNeil MM, Moro PL, Lewis PW, Winiecki SK, Shimabukuro TT. 2015. Adverse events following measles, mumps, and rubella vaccine in adults reported to the Vaccine Adverse Event Reporting System (VAERS), 2003–2013. Clin Infect Dis. 60:e58-65.
157. Hofmann J, Kortung M, Pustowoit B, Faber R, Piskazeck U, Liebert UG. 2000. Persistent fetal rubella vaccine virus infection following inadvertent vaccination during early pregnancy. J Med Virol 61:155158.[PubMed]
158. Plotkin SA, Klaus RM, Whitely JP. 1966. Hypogammaglobulinemia in an infant with congenital rubella syndrome; failure of 1-adamantanamine to stop irus excretion. J Pediatr 69:10851091.[PubMed]
159. Arvin AM, Schmidt NJ, Cantell K, Merigan TC. 1982. Alpha interferon administration to infants with congenital rubella. Antimicrob Agents Chemother 21:259261.[PubMed]
160. Armstrong RD, Sinclair A, O'Keeffe G, Grahame R. 1985. Interferon treatment of chronic rubella associated arthritis. Clin Exp Rheumatol 3:9394.[PubMed]
161. Wolinsky JS, Dau PC, Buimovici-Klein E, Mednick J, Berg BO, Lang PB, Cooper LZ. 1979. Progressive rubella panencephalitis: immunovirological studies and results of isoprinosine therapy. Clin Exp Immunol 35:397404.[PubMed]
162. McLean HQ, Fiebelkorn AP, Temte JL, Wallace GS Centers for Disease Control and Prevention. 2013. Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 62(RR-04):134.[PubMed]
163. Rudolph AJ, Singleton EB, Rosenberg HS, Singer DB, Phillips CA. 1965. Osseous manifestations of the congenital rubella syndrome. Am J Dis Child 110:428433.[PubMed]

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error